Zacks Research issued their FY2027 earnings estimates for shares of Charles River Laboratories International in a report ...

Stock analysts at Zacks Research boosted their FY2027 earnings estimates for shares of Bank of New York Mellon in a report issued on Tuesday, March 11th. Zacks Research analyst R. Department now ...

A recent ransomeware attack targeted Zacks, an American investment firm, and a cybercriminal claimed to have stolen records ...

Wall Street expects a year-over-year decline in earnings on higher revenues when FactSet Research (FDS) reports results for the quarter ended February 2025. While this widely-known consensus outlook ...

ACM Research, Inc. (ACMR) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term.

NEW YORK, NY / ACCESS Newswire / February 24, 2025 / Zacks Investment Research recently disclosed that it suffered a data breach that compromised the sensitive personal data of millions of individuals ...

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Apple Inc., Eli Lilly and Co. and ...

Below are three quality stocks to buy off the rising 200-day moving average: Zacks Rank #2 (Buy) stock On Holding is an emerging leader in the running shoe category. The company has delivered ...

SAN DIEGO (AP) — SAN DIEGO (AP) — Atyr Pharma Inc. (ATYR) on Thursday reported a loss of $15 million in its fourth quarter. The San Diego-based company said it had a loss of 18 cents per share.

For the year, the company reported profit of $1.2 billion, or $25.34 per share. Revenue was reported as $11.3 billion. Ulta expects full-year earnings to be $22.50 to $22.90 per share, with revenue in ...